Skip to content

Effects of respiratory muscle training on the quality of life of hemodialysis patients

Effects of powerbreathe® on hemodialysis quality of life: blind randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8m62y2
Enrollment
Unknown
Registered
2020-06-26
Start date
2020-02-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Failure

Interventions

Participants who meet the eligibility criteria and ICF, will be submitted to three weekly interventions for a month, totaling 10 visits. The consultations will be carried out in approximately 45 minut
Other
H02.010.625

Sponsors

Universidade Luterana do Brasil
Lead Sponsor
Universidade Luterana do Brasil
Collaborator

Eligibility

Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Adult subjects between 18 and 70 years old; Regular hemodialysis at least 3x a week for at least 6 months; Do not practice any type of physical exercise; Having signed the informed consent form (ICF).

Exclusion criteria

Exclusion criteria: Uncontrolled systemic arterial hypertension (SAH); Ischemic heart disease; Amputation; Deep vein thrombosis; Severe dyspnea; Femoral fistula; Chronic obstructive pulmonary disease (COPD) stage 3 (severe); decompensated congestive heart failure (CHF); Cardiac arrhythmia; Severe pneumopathy; Acute systemic infection; Pregnancy; Decompensated diabetes mellitus; Any orthopedic, neurological or cognitive impairment that compromises the understanding and execution of kinesiotherapy programs.

Design outcomes

Primary

MeasureTime frame
Improvement of quality of life, determined through the Kidney Disease and Quality of Life - Short Form 1.3 questionnaire

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactVicente Brito

Universidade Luterana do Brasil

vicentebrito09@gmail.com+55-051-996497380

Outcome results

None listed

Source: REBEC (via WHO ICTRP)